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Abstract Known as one of the hallmarks of cancer [35], cancer cell inva-
sion of human body tissue is a complicated spatio-temporal multiscale process
which enables a localised solid tumour to transform into a systemic, metastatic
and fatal disease. This process explores and takes advantage of the recipro-
cal relation that solid tumours establish with the extracellular matrix (ECM)
components and other multiple distinct cell types from the surrounding mi-
croenvironment. Through the secretion of various proteolytic enzymes such
as matrix metalloproteinases (MMP) or the urokinase plasminogen activator
(uPA), the cancer cell population alters the configuration of the surrounding
ECM composition and overcomes the physical barriers to ultimately achieve
local cancer spread into the surrounding tissue.
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The active interplay between the tissue-scale tumour dynamics and the
molecular mechanics of the involved proteolytic enzymes at the cell-scale un-
derlines the biologically multiscale character of invasion, and raises the chal-
lenge of modelling this process with an appropriate multiscale approach. In
this paper, we present a new two-scale moving boundary model of cancer in-
vasion that explores the tissue scale tumour dynamics in conjunction with the
molecular dynamics of the urokinase plasminogen activation system. Building
on the multiscale moving boundary method proposed in [67], the modelling
that we propose here allows us to study the changes in tissue scale tumour
morphology caused by the cell-scale uPA micro-dynamics occurring along the
invasive edge of the tumour. Our computational simulation results demon-
strate a range of heterogeneous dynamics which are qualitatively similar to
the invasive growth patterns observed in a number of different types of cancer,
such as the tumour infiltrative growth patterns discussed in [38].
Keywords Cancer invasion · Multiscale modelling · uPA system
1 Introduction
Cancer is a complicated disease that involves many cross-related processes
occurring over several spatial scales, ranging from genes to cells to tissues.
The abilities of cancer cells to activate invasion and metastasis, to sustain
proliferative signalling, to evade growth suppressors, to enable replicative im-
mortality, to induce angiogenesis, and to resist cell death, have been initially
identified as the six main hallmarks of cancer [35]. A growing knowledge about
cancer over the last decade has shed more light on the whole picture of the
disease and another four hallmarks were added, namely: the ability of can-
cer to avoid immune destruction, to deregulate cellular energetics, to develop
tumour-promoting inflammations, alongside genome instability and mutations
[36].
Highlighted as one of the hallmarks of cancer, cancer cell invasion is a
landmark event that transforms a locally growing tumour into a systemic,
metastatic and fatal disease. The past four decades have witnessed great sci-
entific efforts focussed on gaining a better understanding of the processes in-
volved during cancer invasion, which is of highly importance in designing early
detection strategies and attempting effective therapies.
A malignant tumour includes a complex heterotypic community of cells
(such as cancer cells, immuno-inflamatory cells, stromal cell, fibroblasts, en-
dothelial cells, macrophages) that are mixed with ECM. This community is
enhanced by vastly complex signalling pathways underpinning intense molecu-
lar processes that mediates the crosstalk between the various cell populations
composing the tumours, such as the interaction between the cancer cells and
the peritumoural stroma cells occurring during cancer invasion [36,49,55,39,
40]. As one of the main factors that affect the way the cancer cell migrate
and invade, the peritumoural ECM not only plays the role of a scaffold for
the tissues and physical barriers during cell migration but also conveys the
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signalling pathway processes, enabling the cells to communicate. These give
rise to specific conditions within the tumour microenvironment that locally
regulate cell migration, proliferation and differentiation. Specifically, the se-
cretion of proteolytic enzymes such as urokinase plasminogen activator (uPA)
and matrix metalloproteinases (MMPs) by the tumour cells and interactions
of these enzymes with the ECM components lead to proteolytic degradation
and remodelling of the ECM and represent a key step in the cancer invasion
process.
In order to decipher the mechanisms behind the complicated processes in-
volved in cancer invasion, clinical investigations and experimental observations
carried out over the past few decades have started being increasingly accom-
panied by mathematical modelling [2,5,13,19,30,33,51,52,69]. These initial
modelling attempts used reaction-diffusion systems to describe the interac-
tion between malignant and normal cells and focused on several important
invasion aspects, leading to the first qualitative mathematical modelling ap-
proaches and paving the way towards a better understanding of the contri-
bution of proteolytic enzymes in cancer invasion. This was further explored
with modelling focused the role of proteolytic activities of some specific hy-
drolytic enzymes such as urokinase plasminogen activator (uPA) and matrix
metalloproteinases (MMPs) in tumour invasive behaviour [4,6,11,17,22,51,
52]. For instance, while [17] proposed a system of reaction-diffusion-taxis par-
tial differential equations to explore the role of the uPA system (including
uPA, uPA-inhibitors, plasmin and host tissue) in cancer invasion, the model
introduced in [22] evaluates the role of two types of simultaneously expressed
MMPs on cancer growth and spread i.e., membrane-bound matrix MT1-MMP
and soluble MMP-2.
Alongside the chemotactic and haptotactic movement assumed in all the
models mentioned above, cell-cell and cell-matrix adhesion were also recog-
nised as playing a crucial role in the growth and development of carcinomas
[13]. Advances in addressing the importance of cell-adhesion in the cancer
invasion process were obtained via several models based on systems of non-
local integro-differential equations [9,16,25,32] that account for dynamic in-
teractions within an appropriately small sensing radius R between potentially
mutating cancer cell populations, ECM, and the involved matrix degradation
enzymes.
Since the local tissue invasion of a malignant tumour could be regarded also
as a free moving boundary problem, several appropriate numerical techniques
were considered in the computational modelling of cancer invasion. Particu-
larly, the level-set method was intensely used to study solid tumour growth
in homogeneous microenvironments [29,43–45,72]. A new ghost cell/level set
method (based of a nonlinear nutrient equation coupled with a pressure equa-
tion with geometry-dependent jump boundary conditions) was developed in
[46] and applied to models of tumour invasive growth in complex, hetero-
geneous tissues. This model was later extended into an improved model of
tumour invasion including the process of tumour-induced angiogenesis [47].
Finally, alongside the level-set method, multiphase models based on the the-
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ory of mixtures were also developed and used to investigate tumour growth
and spread [12,15,27,54,70,71]. In these approaches, the tumour was regarded
as a system consisting of different phases (e.g. cellular phase, liquid phase, etc)
and the development of a solid tumour was modelled by exploring the mass
and momentum balances alongside the constitutive laws that distinguish the
phases in the system.
However, while recognizing the multiscale nature of cancer growth and
spread, over the past two decades or so most computational and mathemat-
ical modelling has focused mainly on one scale, either at the tissue, cell or
molecular scale, with the first attempts towards linking these scales being re-
vised in [24]. Recently, following a series of important developments within the
general multiscale framework, and based on strong insights from atomistic-to-
continuum methods [42], homogenization techniques [3,66], and heterogeneous
multiscale finite element methodology [1,26,57], a genuinely new multiscale
moving boundary model for cancer invasion that links the tissue, cellular and
subcellular scales was proposed in [67]. In this new framework, PDE modelling
at the tissue scale for the cell population dynamics and PDE modelling at the
cell scale for the molecular mechanics of the proteolytic enzymes population
are linked together in a two-scale model through top-down and bottom-up
permanent links. The top-down link provides the source for the micro-scale
dynamics, which is induced in a non-local manner by the macro-dynamics. On
the other hand, the bottom-up link enables the micro-dynamics to provide the
macro-dynamics with a law for the macro-scale boundary movement, whose
direction and displacement magnitude is determined at microscale. This is
fundamentally different from previous modelling perspectives such as the one-
scale modelling presented in [5], or the one proposed in [56] where the authors
considered continuous modelling at the microscale but an individual-based
model at the macroscale and where no top-down links were assumed.
In this paper we propose a novel multiscale mathematical model of can-
cer invasion that explores the tissue scale cancer progression in conjunction
with the cell-scale dynamics of the urokinase plasminogen activation system.
Building on the multiscale moving boundary method proposed in [67], the
new modelling that we propose here allows us to study the changes in tis-
sue scale (macro) tumour morphology caused by the cell-scale uPA micro-
dynamics occurring in a cell-scale (micro) neighbourhood of the invasive edge
of the tumour. Assuming the uPA model developed in [4,17] for the tissue
scale dynamics, we derive governing laws for the degrading enzymes cell-scale
dynamics arising in the close proximity of the tumour interface. While this
results in prescribing an appropriate form for the top-down link between the
macro- and micro- dynamics, by exploring the spatial interaction between the
uPA micro-dynamics and the surrounding ECM from the peritumoural region
we obtain a bottom-up link between the micro- and macro- dynamics. This
allows us to describe the evolution of tumour invasive edge morphology and en-
ables computational predictions for the changes occurring in the macroscopic
pattern of cancer during the local invasion process.
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2 Biological Background: Components of the uPA System and
their Functions
Proteolytic degradation and remodelling of the extracellular matrix is essen-
tial for cancer cell invasion. It enables cancer cells to proliferate and migrate
through surrounding tissue. In this context, one of the first steps of invasion
is the production and secretion of proteolytic enzymes, i.e., urokinase plas-
minogen activator (uPA) and matrix metalloproteinases (MMPs) by cancer
cells. These enzymes interact with the dynamics of the ECM macromolecules
and pave the way for cancer invasion. Specifically, the uPA enzymatic system
mainly consists of the urokinase receptor (uPAR), urokinase plasminogen acti-
vator (uPA), the matrix-like protein vitronectin (VN), plasminogen activator
inhibitor type1 (PAI-1), and the degrading enzyme plasmin. Here we list the
key activities of the main components of the uPA system and the role each
plays in cancer invasion [7,8,21,64].
Urokinase plasminogen activator (uPA). uPA is an extracellular serine pro-
tease produced by cells. Two major functional domains of the uPA molecule
are the protease domain and the growth factor domain. The protease part ac-
tivates plasminogen and turns it into plasmin, which is able to digest basement
membrane and extracellular matrix proteins. The growth factor domain has
no protease activity but can bind a specific high affinity cell-surface receptor,
uPAR. Finally, uPA has a zymogen form, pro-uPA, which can be activated by
plasmin and binds to uPAR.
Urokinase plasminogen activator receptor (uPAR). uPAR is a high affinity
cell-surface receptor of uPA (and of its zymogen form pro-uPA), which via the
binding process localises the uPA and pro-uPA to the cell surface. Importantly,
uPAR contains another binding site for the ECM component called vitronectin
(VN), and since VN and uPA binding sites are distinct, uPAR can simulta-
neously bind both ligands, allowing coordinated regulation of proteolysis, cell
adhesion, and signalling.
uPAR expression during ECM remodelling is well-controlled under normal
conditions, for example, in gestational tissues during embryo implantation and
placental development and in keratinocytes during epidermal would healing.
uPAR is also expressed in many human cancers. It indicates poor prognosis
and in some cases is predictive of invasion and metastasis. Importantly, uPAR
expression in tumours can occur in tumour cells and/or tumour-associated
stromal cells, such as fibroblasts and macrophages. Moreover, there is a certain
crosstalk between these two binding processes, as the ligand-binding of uPA
to uPAR enhances the VN binding by uPAR [62].
Vitronectin (VN). VN is an abundant versatile glycoprotein found in serum
and the ECM and promotes cell adhesion and spreading. Vitronectin binds
strongly to glass surfaces, as the name indicates (vitro = glass), and it has
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binding sites for several ligands, including heparin, urokinase plasminogen ac-
tivator receptor (uPAR), plasminogen activator inhibitor type-1(PAI-1), and
integrins, such as αvβ3. When vitronectin binds to uPAR, it is thought to
bring PAI-1 closer to uPA, thereby promoting inhibition and clearance of uPA
from the receptor.
Urokinase plasminogen activator Inhibitor-1(PAI-1) One of the inhibitors of
urokinase plasminogen activator, PAI-1, belongs to the serpin (serine protein
inhibitors) family and it is believed to be the most abundant, fast-acting in-
hibitor of uPA in vivo. It can specifically bind to soluble and membrane-bound
uPA to inhibit plasminogen activation. When PAI-1 binds to the uPA/uPAR
complex, it triggers the internalisation of the uPA/uPAR/PAI-1 complex by
receptor-mediated endocytosis, meaning that the complex will be dissociated
and PAI-1 and uPA will be digested, but the receptor will be recycled to the
cell surface. This process helps with the clearance of PAI-1 from the vicin-
ity of the cell surface. Additionally, as a major binding protein of VN, PAI-1
competes with uPAR for binding to VN.
Plasmin. Plasmin is a widespread enzyme that cleaves many extracellular ma-
trix proteins, such as fibronectin, laminin, vitronectin and thrombospondin. In
addition, plasmin can also activate many matrix metalloproteinases (MMPs),
enhancing even more the degradation of extracellular matrix. It can also in-
fluence the composition of the extracellular environment by affecting the ac-
tivity of cytokines and growth factors, for example, decreasing the activation
of TGF-β1 [68].
3 Mathematical Modelling
In this section, we will detail the three main components of the uPA multiscale
model that we propose for cancer invasion, namely: the macroscopic dynamics,
the microscopic dynamics and regulation of the tumour boundary relocation.
Thus, the description will cover the model at both the macro level (tissue-
scale) and the micro level (cell-scale), and will explore the link between these
two biological scales.
3.1 The macroscopic dynamics
For the tumour macroscopic dynamics, we adopt here the modelling hypothe-
ses formulated in [4] and [17] which are based on the activities of the key
molecules of the uPA system and their invasive roles [7,8,21,64].
We denote the cancer cell density by c, the extracellular matrix density by
v (without making the distinction between ECM and its component VN), the
urokinase plasminogen activator (uPA) concentration by u, the plasminogen
activator inhibitor (PAI-1) concentration by p and the plasmin concentration
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by m. Further, since we assume a fixed average number of receptors uPAR
located on each cancer cell surface, there is no explicit modelling of uPAR.
Therefore, the concentration of uPAR is considered to be proportional to the
cancer cell density. Another important assumption is that the supply of plas-
minogen is unlimited in this model. Finally, the macroscopic model is obtained
by accounting for the biological considerations described in previous section
in conjunction with the following presumptions:
The cancer cell dynamics. It is assumed that cancer cell migration is mainly
governed by diffusion, chemotaxis due to uPA, and PAI-1 (cf. [23] [58] [59])
and haptotaxis due to VN and other ECM components. Additionally, a logistic
growth law is used to model cancer cell proliferation. Thus, the mathematical
equation for cancer cell density that is considered here is as follows:
∂c
∂t
= Dc∆c︸ ︷︷ ︸
diffusion
−∇ · [ χuc∇u︸ ︷︷ ︸
uPA-chemo
+ χpc∇p︸ ︷︷ ︸
PAI-1-chemo
+ χvc∇v︸ ︷︷ ︸
VN-hapo
] + µ1c(1− c
c0
)︸ ︷︷ ︸
profieration
, (1)
where Dc is the diffusion coefficient of cancer cells, χu and χp are the chemo-
taxis coefficients relevant to uPA and PAI-1 respectively, χv is the VN-mediated
haptotaxis rate, µ1 is the cancer cell proliferation rate, and c0 is the maximum
carrying capacity for cancer cells.
The ECM/VN dynamics. As ECM is not assumed to move, we rule out any
migration terms in the governing law. While VN (which is an important ECM
component) is degraded in contact with enzymes m, the binding of PAI-1 to
uPA inhibits the activation of plasminogen, leading to the protection of VN
and other ECM molecular constituents and indirectly contributing to their
production. Simultaneously, the binding of PAI-1 to VN results in less binding
to cell-surface receptors such as uPAR, and so, through the regulation of cell-
matrix-associated signal transduction pathways, this inhibits the production of
VN. Therefore, assuming a logistic ECM remodelling, the governing equation
for ECM is given by
∂v
∂t
= − δvm︸︷︷︸
degradation
+ φ21up︸ ︷︷ ︸
uPA/PAI-1
− φ22vp︸ ︷︷ ︸
PAI-1/VN
+µ2v(1− v
v0
)︸ ︷︷ ︸
remodelling
. (2)
where δ is the rate of ECM degradation by plasmin, φ21 is the binding rate of
PAI-1 to uPA, φ22 is the binding rate of PAI-1 to VN, and µ2 is the matrix
remodelling rate.
The uPA dynamics. The mathematical modelling of the uPA concentration
dynamics accounts for the following aspects. While being produced by the
cancer cells and removed from the system due to its binding with PAI-1 and
uPAR, per unit time the uPA exercises a local diffusion. Therefore, this can
be formalised mathematically as follows:
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∂u
∂t
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
− φ33cu︸ ︷︷ ︸
uPA/uPAR
+ α31c︸︷︷︸
production
, (3)
where Du is the diffusion coefficient, φ31 and φ33 are binding rates of uPA/PAI-
1 and uPA/uPAR accordingly, and α31 is the production rate of uPA by the
cancer cells.
The PAI-1 dynamics. Similarly, the equation for PAI-1 simply includes a diffu-
sion term with coefficient Dp, removal caused by binding to uPA and VN with
binding rates φ41 and φ42 respectively, and production as a result of plasmin
formation at a rate α41. Thus, these considerations lead us to the following
governing equation:
∂p
∂t
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
− φ42pv︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
. (4)
The plasmin dynamics. The evolution of plasmin concentration is modelled
as follows. While assuming that per unit time this exercises a local diffu-
sion, we consider that the binding of uPA to uPAR provides an opportunity
for pericellular proteolytic activity through plasminogen activation leading to
plasmin formation. Moreover, the binding of PAI-1 to VN indirectly enhances
the binding of uPA to uPAR, therefore bringing additional contribution to
plasmin formation. Thus, these assumptions give us the following evolution
law:
∂m
∂t
= Dm∆m︸ ︷︷ ︸
diffusion
+ φ52pv︸ ︷︷ ︸
PAI-1/VN
+ φ53cu︸ ︷︷ ︸
uPA/uPAR
− φ54m︸ ︷︷ ︸
degradation
, (5)
where Dm is the diffusion coefficient, φ52 and φ53 are the binding rates of PAI-
1/VN and uPAR/uPA accordingly, and φ54 is the rate of decay of plasmin.
To summarise the macro-dynamics, the dimensionless mathematical model
of the uPA system adopted here is the one that was initially proposed in [17],
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namely:
∂c
∂t
= Dc∆c︸ ︷︷ ︸
diffusion
−∇ · [ χuc∇u︸ ︷︷ ︸
uPA-chemo
+ χpc∇p︸ ︷︷ ︸
PAI-1-chemo
+ χvc∇v︸ ︷︷ ︸
VN-hapo
] + µ1c(1− c)︸ ︷︷ ︸
profieration
, (6)
∂v
∂t
= − δvm︸︷︷︸
degradation
+ φ21up︸ ︷︷ ︸
uPA/PAI-1
− φ22vp︸ ︷︷ ︸
PAI-1/VN
+µ2v(1− v)︸ ︷︷ ︸
remodelling
, (7)
∂u
∂t
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
− φ33cu︸ ︷︷ ︸
uPA/uPAR
+ α31c︸︷︷︸
production
, (8)
∂p
∂t
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
− φ42pv︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
, (9)
∂m
∂t
= Dm∆m︸ ︷︷ ︸
diffusion
+ φ52pv︸ ︷︷ ︸
PAI-1/VN
+ φ53cu︸ ︷︷ ︸
uPA/uPAR
− φ54m︸ ︷︷ ︸
degradation
. (10)
We note that the above model was investigated numerically in some depth
in [17], where wide-ranging computational simulations revealed rich spatio-
temporal dynamics. Further numerical investigations on variations of the orig-
inal model (including a reduced model involving only the three variables c, v, u)
were undertaken in [18] where once again solutions displaying a persistent
“dynamic heterogeneity” were observed. An analysis (linear stability) of the
model was later carried out by [4] who demonstrated that the dynamic het-
erogeneous spatio-temporal solutions were caused by a taxis-driven instability
of an underlying spatially homogeneous steady-state. In particular three key
parameters controlling the bifurcations were noted to be Dc (the cancer cell
diffusion coefficient), µ1 (the cancer cell proliferation rate) and φ53 (the rate of
plasmin production due to uPA/uPAR binding). We also note that a rigorous
mathematical analysis of the simplified three-variable system involving only
cancer cells, ECM and uPA (i.e. no PAI-1 and no plasmin) was carried out in
[37] (following a preliminary numerical study in [50]). This rigorous analysis
has shown that the complex dynamics of the model are driven largely by can-
cer cell proliferation and cancer cell chemotaxis. Finally we note that a study
from a numerical analysis point of view concerning mesh-adaptivity has been
undertaken in [41].
3.2 The microscopic dynamics
Turning now our attention to the micro-scale setting, in the following we will
derive and propose a system of three coupled PDEs to describe the micrody-
namics of the plasminogen activation system taking place within a cell-scale
-neighbourhood P of the tumour invasive edge ∂Ω(t0) (which is introduced
in Appendix 6).
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Assuming that PAI-1 and uPAR are uniformly expressed on the cell surface
of various cell types in the tumour, this system will capture the leading edge
micro-dynamics of the uPA, PAI-1 and plasmin by accounting for the following
biological considerations. On one hand, the urokinase plasminogen activator
(uPA) is assumed to bind to the cancer surface receptor uPAR to activate
plasminogen, leading to degradation of pericellular ECM through a series of
proteolytic activities. On the other hand, the membrane-bound MMPs (such
as MT1-MMP) are secreted from within the tumour cell population distributed
on the outer proliferating rim along the entire tumour periphery. Their region
of proteolytic activities is therefore restricted around the tumour interface [22,
61]. Thus, based on these considerations, we propose a coupled governing law
for the leading edge microdynamics, which is detailed as follows:
The uPA microdynamics. In each micro region Y the dynamics of the uPA
molecular population is governed by a diffusion process whose source is induced
from the tumour cell macro-dynamics. At each point y ∈ Y , a source of uPA
arises as a collective contribution of the tumour cells distributed within a cer-
tain neighbouring area within the tumour’s outer proliferating rim. Therefore,
this source is denoted by fY (·, ·)× [0, ∆t] : Y → R+ and is defined by:
f Y1 (y, τ) =
{ 1
λ(B(y,γ)∩Ω(t0))
∫
B(y,γ)∩Ω(t0)
c (x, t0 + τ) dx, y ∈ Y ∩Ω(t0),
0, outside cancer,
(11)
where λ(·) is the standard Lebesgue measure, and γ represents the maximal
thickness of the outer proliferating rim. Thus, per unit time, under the presence
of source (11) the uPA is locally diffusing and is binding to both PAI-1 and
uPAR, and so its microdynamics can be formally written as:
∂u
∂τ
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
+ ( α31︸︷︷︸
production
− φ33u︸︷︷︸
uPA/uPAR
)f Y1 (y, τ) (12)
The PAI-1 microdynamics. The equation for PAI-1 accounts for diffusive mo-
tion, production due to plasmin activation, and loss due to binding with uPA
and VN. Specifically, the binding between PAI-1 and VN is as a collective
effect of the ECM distribution within Y . Therefore, proceeding similarly to
the case of the source term in (11), we define
f Y2 (y, τ) =
1
λ(B(y, 2))
∫
B(y,2)
v (x, t0 + τ) dx, y ∈ Y, (13)
which finally enable us to write the following governing law for the PAI-1
microdynamics, namely:
∂p
∂τ
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
−φ42p f Y2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
. (14)
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The plasmin microdynamics. For the spatio-temporal evolution of plasmin, it
is assumed that, per unit time, this exercises a local diffusion in the presence of
the following source and decay circumstances. Considering that the binding of
uPA to uPAR is required to provide the cell surface with a potential proteolytic
activity, the plasmin source accounts on one hand on the contribution of the
binding uPA/uPAR. On the other hand, as PAI-1 collectively competes with
uPAR for binding to VN, the binding of PAI-1 to VN gives more opportunities
to uPAR to bind with uPA, and indirectly results in more plasmin formation.
Finally, plasmin can be deactivated either by degradation or by the action of
the plasmin inhibitor α2-antiplasmin. Thus, the equation that we obtain to
describe these biological interactions is:
∂m
∂τ
= Dm∆m︸ ︷︷ ︸
diffusion
+φ52p f
Y
2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+φ53u f
Y
1 (y, τ)︸ ︷︷ ︸
uPA/uPAR
− φ53m︸ ︷︷ ︸
degradation
(15)
In summary, the leading edge microdynamics is therefore given by the
following system:
∂u
∂τ
= Du∆u︸ ︷︷ ︸
diffusion
− φ31pu︸ ︷︷ ︸
uPA/PAI-1
+ ( α31︸︷︷︸
production
− φ33u︸︷︷︸
uPA/uPAR
)f Y1 (y, τ), (16)
∂p
∂τ
= Dp∆p︸ ︷︷ ︸
diffusion
− φ41pu︸ ︷︷ ︸
uPA/PAI-1
−φ42p f Y2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
, (17)
∂m
∂τ
= Dm∆m︸ ︷︷ ︸
diffusion
+φ52p f
Y
2 (y, τ)︸ ︷︷ ︸
PAI-1/VN
+φ53u f
Y
1 (y, τ)︸ ︷︷ ︸
uPA/uPAR
− φ54m︸ ︷︷ ︸
degradation
. (18)
3.3 The macroscopic tumour boundary relocation induced by the leading
edge micro-dynamics
Following the multiscale approach described in Appendix 6, the set of points
{x∗Y } on the boundary of tumour at the current time moves towards a set of
new spatial positions {x˜∗Y } to form the new boundary at the next multiscale-
stage, provided that the local transitional probability q∗ is in agreement with
the circumstances in the surrounding peritumoural microenvironment. When
the invading strength is above a tissue threshold, the point x∗Y will relocate
to a new position x˜∗Y following a direction and displacement magnitude that
represents the choreographic movement of all the points from the part of the
invasive edge captured by the micro-domain Y .
As described in Appendix 6.2, on any micro-domain Y , provided that a
sufficient amount of plasmin has been produced across the invading edge, it is
the pattern of the front of the advancing spatial distribution of plasmin that
characterises ECM degradation. Therefore, the movement direction and dis-
placement magnitude of the part of the invading edge of the tumour caputred
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by the current micro-domain Y will be determined by the spatial distribution
pattern of the advancing front of plasmin m(·, τf ) in the peritumoural region.
As detailed in Appendix 6.2, these movement characteristics are obtained by
accounting the contribution of all peaks (baricentred at the spatial points yl)
at the front of advancing plasmin that are above the mean value of the en-
tire mass of plasmin produced on Y \Ω(t0) and are located at the furthest
away Euclidean distance from {x∗Y }. Thus, under these conditions, the mov-
ing direction ηY and displacement magnitude ξY derived in Appendix 6.2 in
(35)-(36) have the following expressions:
ηY = x
∗
Y + ν
∑
l∈Iδ
(∫
Dl
m(y, τf )dy
)
(yl − x∗Y ), ν ∈ [0,∞],
ξY :=
∑
l∈Iδ
∫
Dl m(y, τf )dy∑
l∈Iδ
∫
Dl m(y, τf )dy
∣∣−−−→x∗Y yl∣∣.
Finally, the transitional probability q∗ defined in (37) is a quantification of
the amount of plasmin in Y \Ω(t0) relative to the total amount of plasmin
concentration in Y and characterizes the invading strength. Therefore, the
point x∗Y will exercise the movement into the new spatial position x˜
∗
Y if and
only if q(x∗Y ) := q
∗(Y ) exceeds a certain tissue local threshold ω(β, Y ) ∈
(0, 1) associated with the micro-domain Y under a given state of favourable
conditions β.
4 Multiscale Computational Simulation Results
The multiscale model of cancer invasion that we proposed here was numerically
solved in a rectangular region Y := [0, 4 × [0, 4]. For all our simulations, we
discretise the entire cube Y uniformly, using the spatial mesh size: ∆x = ∆y =

2 = 0.03125. In this context, the initial conditions for the macro-dynamics
are specified as follows. The cancer cell population on the initially considered
tumour region Ω(0) := B((2, 2), 0.5) is assumed to be given by a translated
Gaussian centred at (2, 2) and mollified to 0 after a radius of 0.5, namely:
c(x, 0) =
(
exp
(− ||x−(2,2)||22√
∆x∆y
)− exp(−28.125))(χ
B((2,2),0.5−γ) ∗ ψγ
)
2
, x ∈ Y,
(19)
where ψγ is the mollifier defined in (40)-(41) with γ <<
∆x
3 . Further, the
initial macroscopic conditions for the enzymatic components entering the uPA
system are considered as follows:
u(x, 0) = 1− 12c(x, 0), x ∈ Y
p(x, 0) = 12c(x, 0), x ∈ Y
m(x, 0) = 120c(x, 0), x ∈ Y
(20)
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Fig. 1: Initial conditions of the distributions of cancer cells (left column) and
ECM (right column) and the invasive boundary of the tumour (white line) for
the homogeneous case (top row) and the heterogeneous case(bottom row).
At the same time, in all the subsequent simulations, we consider the following
homogeneous and heterogeneous initial condition for ECM, namely:
homogeneous case: v(x, 0) = 1− c(x, 0), x ∈ Y,
heterogeneous case: v(x, 0) = 1+0.3 sin (4pi||x||2)+sin (4pi||(4,0)−x||2)2 , x ∈ Y.
(21)
Figure 1 shows the initial conditions (19) and (21) of ECM and cancer cell
distributions for both homogeneous and heterogeneous cases that are used in
all the simulations presented in this paper.
Finally, in the absence of medical data, for the tissue threshold ω(β, Y )
controlling whether or not a point on the boundary will exercised the move-
ment according to the direction and displacement magnitude defined in Ap-
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pendix 6.2, we adopt the following functional form:
ω(β, Y ):=

sin
(
pi
2
(
1− 1β
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
)
if
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
≤β
sin
(
pi
2(1−β)
(
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
−β
)
if
vω(t0)(x
∗
Y ,t0+∆t)
sup
ξ∈∂Ω(t0)
vΩ(t0)(ξ,t0+∆t)
>β
(22)
where β ∈ (0, 1) is a parameter that controls a certain “optimal level” of ECM
degradation and consider this as being the indicator of the most favourable
invasion conditions at the level of tumour and tissue microenvironment. This
functional form of ω rules out any invasion if either a complete destruction
or a very superficial degradation of the surrounding ECM is performed by
the MDEs. This is due to the fact that while for invasion the cancer cells
need considerable level of the ECM degradation, a total destruction of the
surrounding ECM structure prevents them to advance further into the tissue,
as they need some of the ECM components to adhere to in order to migrate.
Finally, while this functional form of the tissue threshold aimed to showcase the
proposed multiscale modelling framework, future work seeks to infer ω(·, Y )
from medical imaging data of the peritumoural tissue.
The following figures show the simulation results of the evolving cancer cell
and ECM spatial distributions and of the invasive tumour boundary at macro-
time stage 20, 40, 60. The images are presented in two columns, with the left
columns representing the cancer cell distribution and right columns showing
the corresponding ECM concentrations. Furthermore, all these images include
the tumour boundary.
In the subsequent simulations, for the macroscopic part of the model, ex-
cept otherwise stated, we will generally be using the following basic set of
parameter values P :
Dn= 4.3×10−3, χu= 3.05×10−2, χp= 3.75×10−2, χv= 2.85×10−2,
µ1 = 0.25, δ= 1.5, φ21 = 0.75, φ22 = 0.55,
µ2 = 0.15, Du= 2.5× 10−3, φ31 = 0.75, φ33 = 0.3,
α31 = 0.215, Dp= 3.5× 10−3, φ41 = 0.75, φ42 = 0.55,
α41 = 0.5, Dm= 4.91× 10−3, φ52 = 0.11, φ53 = 0.75,
φ54 = 0.5, (23)
which are detailed in Table 1 in Appendix 7.3. However, in order to investi-
gate different cancer growth patterns, as described in the following simulation,
we will perform numerical tests also for slightly changed values for the diffu-
sion coefficient of cancer cells Dc, the ECM proliferation rate µ2, or the ECM
degradation rate δ. Also, we will explore a range of values for parameter β, to
highlight the correlation between changes in tissue microenvironment condi-
tions conditions and the resulting cancer invasion patterns.
In order to analyse the effect of each variables (namely, ECM initial condi-
tion, cancer cell diffusion coefficient, ECM proliferation & degradation rates,
and threshold coefficient), we will split the results into four groups as follows:
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Fig. 2: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white
line) at various macro-micro stages: Stage 20, 40, 60. Starting from the homo-
geneous initial conditions shown in Figure 1, these results were obtained for
Dc = 4.3× 10−3, β = 0.775, µ2 = 0.01 and δ = 1.5.
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Fig. 3: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white
line) at various macro-micro stages: Stage 20, 40, 60. Starting from the het-
erogeneous initial conditions shown in Figure 1, these results were obtained
for Dc = 4.3× 10−3, β = 0.775, µ2 = 0.01 and δ = 1.5.
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ECM initial condition. To investigate what effect do different ECM initial con-
ditions have on the whole dynamics of the model, we apply the same threshold
function for both homogeneous and heterogeneous ECM scenario.
The ECM heterogeneity gives rise to a tumour-tissue interaction that is
naturally more complex than in the case of homogeneous ECM. A direct con-
sequence of this is that the ECM heterogeneity triggers a corresponding intrin-
sic variability in the tissue thresholds, which explore the peritumoural tissue
conditions that the cancer interacts with during invasion. This results in a
higher degree of complexity in the spatial structure of the regions with most
favourable conditions for the tumour to progress further in the surrounding
region, within the directions and displacement magnitudes specified by the
microscale dynamics. Ultimately, this gives rise to a higher level of fingering
and infiltrative patterns in the heterogeneous case as opposed to the homo-
geneous case. This is confirmed by our results presented in Figure 3 that
are obtained for the heterogeneous ECM, which exhibit more “fingered” and
infiltrative spreading of the tumour compared with those obtained in the ho-
mogeneous ECM case shown in Figure 2. This type of fingering patterns are
often observed in medical imaging data, such as the one reported in the case
of oesophageal and lung cancer by the authors in [38] and [48], respectively.
Cancer cell diffusion coefficient Dc. As was demonstrated in [37] and [50], the
chemotaxis terms in the cancer cell equation (6) are the main causes of the
occurrence of heterogeneous patterns inside the tumour domain. Therefore, if
the cancer cell diffusion coefficient (Dc) is increased to be one order magni-
tude larger than the chemotaxis coefficients (χu and χp), which becomes the
dominant mechanism of cell movement, then no heterogeneous dynamics will
occur inside the tumour as shown in Figure 4. In Figure 5, the chemotaxis
coefficients are one order magnitude larger than the diffusion coefficient, and
as a consequence we obtain heterogeneous pattern formation of cancer cells,
which leads to a more dynamic tumour boundary deformation.
ECM proliferation rate µ2 & degradation rate δ. From all the simulation re-
sults presented so far, we conclude that the degradation of ECM facilitates
cancer invasion. However, as shown also in several interdisciplinary biological
investigations [30,31,63], the invasion process will stop where ECM is de-
graded a lot. This captures the biological scenario in 2D that when cell-matrix
adhesion is too low, no focal adhesions or stress fibres are formed, and the
cells do not move. In order to investigate the effect of ECM proliferation and
degradation on the invasion process, we compare two groups of parameters: 1)
µ2 = 0.01, δ = 1.5 (non-zero proliferation rate with relatively large degrada-
tion rate, Figure 6); 2) µ2 = 0, δ = 0.75 (no proliferation with relatively small
degradation rate, Figure 7). From these two groups of images, we observe that
when proliferation is present and the degradation rate is relatively large, de-
formations of the boundary is not as dynamic as that when the proliferation
term is absent with a relatively small degradation rate. The reason could be
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Fig. 4: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white
line) at various macro-micro stages: Stage 20, 40, 60. Starting from the het-
erogeneous initial conditions shown in Figure 1, these results were obtained
for Dc = 1.4× 10−2, β = 0.775, µ2 = 0 and δ = 0.75.
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Fig. 5: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white
line) at various macro-micro stages: Stage 20, 40, 60. Starting from the het-
erogeneous initial conditions shown in Figure 1, these results were obtained
for Dc = 4.3× 10−3, β = 0.775, µ2 = 0 and δ = 0.75.
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that the proliferation term will reduce the degree of heterogeneity of the dis-
tribution of ECM, which leads to a less fingered spreading of the cancer cell
population.
Figure 8 shows the results of simulations at the macro-micro stage 60 where
the ECM proliferation rate parameter µ2 was increased over a range of values in
the interval [0.0005, 0.005]. The figures show that, over the range chosen, there
is little difference in either the overall extent of invasion or the morphology
of the invading cancer. Figure 9 shows the results of simulations at the same
macro-micro stage 60 where the degradation parameter δ was increased over
the interval [0.5, 1]. The figures show that, over the range chosen, the extent
of the invasion is similar, but the morphology of the invading cancer changes
slightly from a more fingered boundary to a less fingered boundary. Finally,
as the two parameters µ2 and δ are varied, both Figure 8 and Figure 9 exhibit
spatial consistency aspects in the invasion pattern.
Threshold coefficient β. Finally, Figure 10 shows us comparative results at
macro-micro stage 60 for several values of the threshold coefficients β in the in-
terval [0.7625, 0.7875]. Since β controls the “optimal level” of ECM density for
cancer cells to migrate, its variation gives us different invasion morphologies,
as expected. Again, as we noticed also in the cases of Figure 8 and Figure 9,
a quick comparison between consecutive rows of images (from top to bottom)
in Figure 10 seems to indicate a certain degree of consistency in the changes
occurring in the tumour morphology and “fingered” boundary deformations
with respect to increasing β parameter. This consistency aspect is currently
under investigation and will form the topic of a separate research work.
5 Conclusion
In this paper, we presented and developed a mathematical model of cancer in-
vasion based on the previous work in [4,17] and [67]. We adapted and extended
the two-scale technique in [67] to cope with the different settings that enable
the coupling of the finite-difference uPA macro-solver and a new finite element
micro-solver developed for the newly proposed leading edge micro-dynamics.
This enabled us to simulate the multiscale process of cancer invasion by ex-
ploring the link between the macroscopic dynamics of the spatio-temporal dis-
tribution of cancer cells and ECM taking place on a macroscopic domain, and
the matrix degrading enzymes microdynamics developed on the microscopic
domains that are in close proximity to tumour boundary.
We derived a new governing law for the micro-dynamics based exclusively
on the molecular mechanics of the uPA system occurring in close proximity to
the tumour boundary. This is based on the dynamics of the uPA system in-
cluding uPA, the inhibitor uPA-1 and plasmin, and considers the source terms
related to macroscopic components, i.e. cancer cells and ECM molecules, in
a collective fashion and we solve this new microscopic uPA system by finite
element method. While this is sourced from within the macrodynamics via
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Fig. 6: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white
line) at various macro-micro stages: Stage 20, 40, 60. Starting from the het-
erogeneous initial conditions shown in Figure 1, these results were obtained
for Dc = 4.3× 10−3, β = 0.7625, µ2 = 0.005 and δ = 1.5.
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Fig. 7: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white
line) at various macro-micro stages: Stage 20, 40, 60. Starting from the het-
erogeneous initial conditions shown in Figure 1, these results were obtained
for Dc = 4.3× 10−3, β = 0.7625, µ2 = 0 and δ = 0.75.
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Fig. 8: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line)
at macro-micro stage 60. Starting from the heterogeneous initial conditions
shown in Figure 1, these results were obtained for Dc = 4.3×10−3, β = 0.7625,
δ = 1.5, and for rows 1 to 3 of images we consider µ2 = 0.0005, µ2 = 0.001,
and µ2 = 0.005, respectively.
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Fig. 9: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line)
at macro-micro stage 60. Starting from the heterogeneous initial conditions
shown in Figure 1, these results were obtained for Dc = 4.3 × 10−3, µ2 = 0,
β = 0.7625, and for rows 1 to 3 of images we consider δ = 0.5, δ = 0.75, and
δ = 1, respectively.
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Fig. 10: Simulation results showing distributions of cancer cells (left column)
and ECM (right column) and the invasive boundary of the tumour (white line)
at macro-micro stage 60. Starting from the homogeneous initial conditions
shown in Figure 1, these results were obtained for Dc = 4.3 × 10−3, δ = 1.5,
µ2 = 0.01, and for rows 1 to 3 of images we consider β = 0.7625, β = 0.775,
and β = 0.7875, respectively.
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a top-down link, in our multiscale method (described in Appendix 6.2) the
microdynamics occurring at the cell-scale neighborhood of the tumour is rep-
resented back at the macroscale through a bottom-up feedback by defining
the movement direction and displacement magnitude of the tissue-scale tu-
mour boundary. By coupling this new microscopic governing law for the lead-
ing edge microdynamics with the macroscopic model for the uPA system and
cancer invasion proposed in [4,17], we are able to capture an important class of
multiscale dynamic interactions between cancer cells, ECM molecules, cancer
associated matrix degrading enzymes, and the peritumoural tissue conditions,
leading to significant changes in tumour morphology during invasion.
From the computational simulation results of our model, we can see that
the extended two-scale technique coupled with the uPA system and more spe-
cific modelling of the pericellular proteolytic activities, gives more adverse dy-
namics in the invading cancer. Values of the ECM initial condition, the cancer
cell diffusion coefficient, the threshold coefficient, and the ECM proliferation
& degradation rates all have an impact on the deformations of the tumour
boundary. While for simulating the proposed non-dimensional model we con-
sidered functional formulations for the initial conditions and tissue thresholds,
future work will attempt to assimilate the heterogeneity of ECM and as well as
the peritumoural tissue conditions from imaging data. Finally, concerning the
transitional probability that arises naturally at the micro-scale and intervenes
in the bottom-up link between micro and macro scales, while the simulations
presented in this paper are deterministic, future work will assess the stochastic
character of the overall model.
The conclusions that can be drawn from the qualitative results presented
in this paper are: 1) a heterogeneous ECM initial condition leads to more
fingered spreading of the tumour compared with that in the homogeneous
ECM; 2) in order to obtain heterogeneous patterns of cancer cells inside the
tumour region, chemotaxis must be dominant to drive the cells migration; 3)
the changes of threshold coefficient will definitely affect the boundary defor-
mations, and there is a tendency that the increase of β reduces the number of
‘fingers’ of the interface; 4) without a proliferation term of ECM coupled with
a relatively small degradation rate, deformations of the boundary show more
fingering. However, further investigations are required to analyse the observed
fingering. For instance, the dependence of the width of the fingers on the size
of the microscale and potentially on other regulatory parameters remains an
open question and is an important objective of a future work on the propose
modelling framework.
It is useful to compare these results with other models of cancer growth
and invasion, particularly those that adopt an alternative modelling approach
such as hybrid continuum-discrete, cellular-Potts or cellular automaton, as
well as partial differential equations (PDE) models. Many PDE models of solid
tumour growth and development (including invasion) have modelled cell-cell
adhesion at the outer boundary (or invading edge) of the tumour as a surface-
tension-like force [13,14]. A reduction in surface tension i.e. interpreted as a
loss of cell-cell adhesion then leads to an instability at the invading edge which
A multiscale mathematical model of tumour invasive growth 27
manifests itself in a subsequent growth consisting of finger-like protrusions.
This effect was shown computationally by [20] and [45] who demonstrated
a range of fingering patterns as a cell adhesion parameter was varied. Sim-
ilar spectra of invasive patterns have been observed when adopting either a
cellular-Potts approach [53] or a hybrid continuum-discrete approach [6] i.e.,
by varying a key cell-cell adhesion parameter of the model, invasive fingering
patterns can either be enhanced or suppressed. In the specific case of glioma
invasion, four different approaches – PDE, cellular-Potts, lattice-gas automa-
ton, cellular automaton – have each investigated the role of cell-cell adhesion
and compared computational simulation results with experimental data [10,
28,60,65]. Given these results, we are currently extending our current model
to include cell-cell adhesion.
As the main purpose of this work was to formulate a novel non-dimensional
two-scale modelling platform that simultaneously explores spatio-temporal dy-
namics at both macro-scale (cell population level) and micro-scale alongside
the links in between the two scales, the simulations presented here have a
qualitative character. Future work will explore the possibilities of dimension-
alising and calibrating the proposed multiscale model with measured data at
both macroscopic (tissue-scale) and microscopic (cell-scale) levels to obtain
quantitative simulation that we could compare with clinical observations.
The two-scale modelling modelling described provides a useful mathemat-
ical platform to capture and investigate processes at different levels during
cancer invasion. However, further details remain to be explained on the dy-
namics and interactions of the tumour cell community at the macro-level and
the micro-level as well as regarding the links in between these two scales.
Various avenues could be pursued to extend our modelling by exploring for
instance other ways to determine the cancer cell population macro-dynamics
(for example, change the definition of the threshold function ω characteris-
ing the interaction with the peritumoural tissue) or by accounting for more
complex signalling mechanisms in the establishment of more detailed micro-
dynamics as well as the appropriate top-down and bottom-up links between
these different levels (scales) of the invasion process.
6 Appendix: The Two-Scale Computational Modelling Method
In the following we will briefly present the technique introduced in [67] and
adjust this with all the details to our new situation. For completion, we in-
troduce here all the necessary notations and describe the defining principles
that are referred to in the paper, as well as the relevant considerations and
explanations concerning our new model.
6.1 Preliminary considerations and notations
It is assumed that the domain within which the cancer and extracellular matrix
exists is a maximal reference spatial cube Y ⊂ Rn(n = 2, 3) with its centre at
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the origin. Given a fixed  representing a negative power of 2 (i.e., 0 <  < 1),
the initial Y is uniformly decomposed -size cubes, Y , whose union will be
referred to as an -resolution of Y . For any Y from the decomposition, the
“half-way shifted” cubes in the direction ie¯1 + je¯2 + ke¯3 given by any triplet
(i, j, k) ∈ {(i, j, k)|i, j, k ∈ {−1, 0, 1}} are defined as
Y i
2 ,
j
2 ,
k
2
= Y +
(ie¯1 + je¯2 + ke¯3)
2
, (24)
where,
e¯1 : = e1, e¯2 : = e2, and, e¯3 : =
{
e3 for N = 3,
0 for N = 2,
(25)
and {e1, e2, e3} is the standard Euclidean basis of R3. The family of all these
−cubes is denoted by F , i.e.,
F :=
⋃
i,j,k∈{−1,0,1}
{
Y i
2 ,
j
2 ,
k
2
∣∣Y is in the -resolution of Y }. (26)
In Figure 11, the notations mentioned so far are illustrated schematically.
Fig. 11: Schematic diagram showing the cubic region Y centred at the origin
∈ R3. The dashed blue lines represent the Euclidean directions {e1, e2, e3},
the pink region illustrates the cancer cluster Ω(t0), and the solid blue line
represents the family of microscopic cubic domains Y placed at the boundary
∂Ω(t0).
In order to capture mathematically the microdynamics that occur in a
cell-scale neighbourhood of the tumour boundary ∂Ω(t0), out of the initial
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family F , we will focus our attention of the subfamily denoted by FΩ(t0) which
consists of only the −cubes that cross the interface ∂Ω(t0) and have exactly
one face included in the interior of Ω(t0), namely
FΩ(t0) := {Y ∈ F|Y ∩ (Y \Ω(t0)) 6= ∅,
and Y has only one face included in int(Ω(t0))}, (27)
where int(Ω(t0)) is the topological interior of Ω(t0) with respect to the natural
topology on Rn. In this context, for each Y ∈ FΩ(t0), we have the following
Fig. 12: Schematic diagram illustrating the notations introduced in (28), (32).
For the arbitrary microdomain Y ∈ P, we indicate with a black arrow the
features: Γ intY , Γ
j1,⊥
Y , and Γ
j2,⊥
Y , j1, j2 ∈ {1, ..., 2N−1}, Γ ‖Y , xcY , µY , and
x∗Y . The arbitrary cube Y ∈ P∗ is shown in green, while the corresponding
half-way shifted Y signi
2
∈ Pthat are not chosen in P∗ are shown in the blue
dashed line.
face-notations:
Γ intY denotes the face of Y that is included in int(Ω(t0)),
Γ j,⊥Y , j = 1, ..., 2
N−1, denote the faces of Y that are perpendicular to Γ intY
Γ
‖
Y denotes the face of Y that is parallel to Γ
int
Y .
(28)
These are illustrated schematically in Figure 12.
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Furthermore, for each Y ∈ FΩ(t0), the topological closure of the only
connected component of Ω(t0) ∩ Y that is confined between [∂Ω(t0)]Y and
Γ intY is denoted by [Ω(t0)]Y . Moreover, denoting by [∂Ω(t0)]Y the connected
component part of ∂Ω(t0) ∩ Y with the property that
[∂Ω(t0)]Y ∩ Γ j,⊥Y 6= ∅ for any j = 1, 2, ..., 2n−1, (29)
we can observe that [∂Ω(t0)]Y represents the part of ∂Ω(t0) ∩ Y that cor-
responds to [Ω(t0)]Y , and is actually the only connected component of this
intersection that has property (29). Finally, using this observation, for the
currently fixed , the subfamily denoted by P consisting of all those −cubes
that have [Ω(t0)]Y not touching Γ
‖
Y is selected as follows:
P := {Y ∈ FΩ(t0)| [Ω(t0)]Y ⊂ Y and [∂Ω(t0)]Y ∩ Γ ‖Y = ∅}. (30)
Leaving now  to take all the negative powers of 2, the union
⋃
∈{2−k | k∈N}
P
provides an infinite covering of ∂Ω(t0). Since ∂Ω(t0) is compact, using stan-
dard compactness arguments, a finite complete sub-covering of ∂Ω(t0) that
consist only of small cubes an equal size ∗ is denoted by P∗ , i.e.,
∂Ω(t0) ⊂
⋃
Y ∈P∗
Y. (31)
Together with this finite complete covering P∗ of the tumour interface ∂Ω(t0),
at each time of the tumour evolution we obtain also the size of the micro-
scale ∗ [67]. For simplicity, in this paper, the size of the cell-scale ∗ will
still be denoted by . Finally, for each Y ∈ P∗ , we distinguish the following
topological details:
xcY denotes the centre of the face Γ
int
Y ,
µY , is the line that passes through x
c
Y and is perpendicular on Γ
int
Y
x∗Y ∈ [∂Ω(t0)]Y which will be referred to as the “midpoint” of [∂Ω(t0)]Y ,
represents the point from the intersection µY ∩ [∂Ω(t0)]Y that is located
at the smallest distance with respect to xcY .
(32)
The well-posedness of these topological features is discussed in [67], and these
are illustrated in Figure 12.
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6.2 The multiscale moving boundary approach for the proposed cancer
invasion model
In the following, we will explain how the set of midpoints {x∗Y }Y ∈P∗ defined
on the boundary of tumour at the current time moves to a set of new spatial
positions {x˜∗Y }Y ∈P∗ to form the new boundary at the very next time, by
describing the movement of one such midpoint x∗Y ∈ [∂Ω(t0)]Y for any Y ∈
P∗ .
Based on biological observations that, on any micro domain Y , provided
that a sufficient amount of plasmin has been produced across the invading
edge and it is the pattern of the front of the advancing spatial distribution
of plasmin that characterised ECM degradation, therefore it is assumed that
each boundary midpoint x∗Y ∈ [∂Ω(t0)]Y will be potentially relocated in
a movement direction and by a certain displacement magnitude dictated by
the spatial distribution of plasmin obtained via the micro process on Y at
the final micro-time τf := ∆t, namely, m(·, τf ). In the following, we explain
how the movement direction and displacement magnitude are defined for each
x∗Y ∈ [∂Ω(t0)]Y .
For any given threshold δ > 0 and any fixed Y ∈ P∗ , the regularity prop-
erty of Lebesgue measure [34] is used to select the first dyadic decomposition
{Dj}j∈Jδ of Y such that
λ
(
[Y \Ω(t0)] \
⋃
{j∈Jδ |Dj⊂Y \Ω(t0)}
Dj
)
≤ δ. (33)
which simply means that Y \Ω(t0) is approximated with accuracy δ by the
union of all the dyadic cubes that this includes. Once this dyadic decomposition
is selected, we denote by yj the barycenters of Dj , for all j ∈ Jδ. As discussed
in [67] for all Y ∈ P∗ , this provides a resolution at which we read the further
away part of the level set 1λ(Y \Ω(t0))
∫
Y \Ω(t0)m(y, ·)dy in the distribution of
the advancing degrading enzymes m(·, ·) outside Ω(t0) in radial direction with
respect to the midpoint x∗Y . Therefore, this enable us to locate dyadic pixels
Dl that support the peaks at the tip of the plasmin front with significant
contribution in degrading the ECM. Hence, at the final microscopic time τf ,
the pixels supporting these peaks are therefore selected as
Iδ :=

l ∈ Jδ
∣∣∣∣∣∣∣∣∣∣∣∣
∃r ∈ S1 such that, if the index i ∈ Jδ has the properties:
1)Di ∩ {x ∈ Rn |x = x∗Y + αr, α ∈ R} 6= ∅,
2)Di ⊂ Y \Ω(t0),
3) 1λ(Di)
∫
Di m(y, τf )dy ≥ 1λ(Y \Ω(t0))
∫
Y \Ω(t0)m(y, τf )dy,
then
l = argmax{d(x∗Y , yi) | i ∈ Jδ satisfies:1), 2), and3)}

,
(34)
where S1 ⊂ Rn is represents the unit sphere, and d(·, ·) is the Euclidean
distance on Rn. Thus, cumulating the driving ECM degradation forces spanned
by each front peak of plasmin given by the dyadic pixels Dl with l ∈ Iδ in
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the direction of the position vectors
−−−−→
x∗Y , yl and appropriately representing the
amount of plasmin that each Dl supports, the revolving direction of movement
ηY for the potential displacement of x
∗
Y is given by:
ηY = x
∗
Y + ν
∑
l∈Iδ
(∫
Dl
m(y, τf )dy
)
(y − x∗Y ), ν ∈ [0,∞]. (35)
Further, the displacement magnitude of the point x∗Y is defined as:
ξY :=
∑
l∈Iδ
∫
Dl m(y, τf )dy∑
l∈Iδ
∫
Dl m(y, τf )dy
∣∣−−−→x∗Y yl∣∣. (36)
Finally, as debated in [67], although a displacement magnitude and a moving
direction is derived for each x∗Y , this will only exercise the movement if and
only if the ECM degradation were of a certain local strength. The strength of
ECM degradation within Y is explored by the transitional probability
q∗ :
∑ ⋃
Y ∈P∗
Y
→ R+
defined as
q∗(G) :=
1∫
G
m(y, τf )dy
∫
G\Ω(t0)
m(y, τf )dy, for all G ∈
∑ ⋃
Y ∈P∗
Y

(37)
where
∑( ⋃
Y ∈P∗
Y
)
represents the Borel σ−algebra of ⋃
Y ∈P∗
Y . Locally, in
each Y , equation (37) is in fact a quantification of the amount of plasmin
in Y \Ω(t0) relative to the total amount of plasmin concentration in Y . In
conjunction with the local tissue conditions, this characterises whether the
point x∗Y is likely to relocate to the new spatial position x˜
∗
Y or not.
Now, by assuming that the point x∗Y is moved to the position x˜
∗
Y if and
only if q∗(x∗Y ) := q
∗(Y ) exceeds a certain threshold ωY ∈ (0, 1), we find
that the new boundary ∂Ω(t0 +∆t) will be the interpolation of the following
set of points:
{x∗Y |Y ∈ P∗Y and q(x∗Y ) < ωY } ∪ {x˜∗Y |Y ∈ P∗Y and q(x∗Y ) ≥ ωY }
(38)
Finally before moving to the next time-step of the whole macro-micro two
scale system, we replace the initial conditions of the macroscopic dynamics
with the solution at the final time of the previous invasion step as follows:
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cΩ(t0+∆t)(x, t0) := c(x, t0 +∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ),
vΩ(t0+∆t)(x, t0) := v(x, t0 +∆t)(χY \ ⋃
Y∈P∗
Y
∗ ψγ),
uΩ(t0+∆t)(x, t0) := u(x, t0 +∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ),
pΩ(t0+∆t)(x, t0) := p(x, t0 +∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ),
mΩ(t0+∆t)(x, t0) := m(x, t0 +∆t)(χΩ(t0)\
⋃
Y∈P∗
Y
∗ ψγ). (39)
Here χ
Ω(t0)\
⋃
Y∈P∗
Y
∗ψγ and χY \ ⋃
Y∈P∗
Y
∗ψγ are the characteristic functions
corresponding to the sets Ω(t0)\
⋃
Y ∈P∗
Y and Y \ ⋃
Y ∈P∗
Y , and choosing γ 

3 , ψγ : R
n → R+ is constructed as a smooth compact support function with
sup(ψγ) = {z ∈ Rn|||z||2 ≤ γ}. This is defined by the standard mollifier
ψ : Rn → R+, namely,
ψγ(x) :=
1
γn
ψ(
x
γ
), (40)
and,
ψ(x) :=

exp( 1
x2−1 )∫
{z∈Rn|||z||2≤γ}
exp( 1
z2−1 )dz
if ||x||2 < 1,
0 if ||x||2 ≥ 1,
(41)
Then, the invasion process will continue on the new expanded domain Ω(t0)
with the macroscopic system and the new initial conditions in (39) at macro-
level followed by proteolytic microprocesses around its boundary, which again
governs the movement of the boundary of the next time multiscale stage.
7 Appendix: Description of the multiscale numerical approach
We compute and solve the multiscale model in a two-dimensional setting by
using computational approach based on a finite difference scheme for macro-
dynamics and finite element approximation for the microdynamics occurring
on each of the boundary Y microdomains. In the following subsections we de-
tail the computational approach and present the steps of the overall multiscale
algorithm.
7.1 The macroscopic stage of the numerical scheme
Since the macroscopic dynamics are taking place in the cube Y , we discretise
the entire Y by considering a uniform spatial mesh of size h := 2 , i.e., ∆x =
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∆y = h. And, the time interval [t0, t0 + ∆t] is discretised in k uniformly
distributed time steps, i.e., using the uniform time step δτ := ∆tk . The temporal
discretisation of the reaction-diffusion system (6) - (10) that we used here is
a second-order trapezoidal scheme, while the diffusion term and haptotactic
terms are approximated with a second-order midpoint rule. For instance, for
the diffusion and haptotactic terms involved in (6), we approximate ∇· (∇c)ni,j
and ∇ · (c∇v)ni,j as follows:
∇·(∇c)ni,j = div(∇c)ni,j
'
(cx)
n
i+ 12 ,j
− (cx)ni− 12 ,j
∆x
+
(cy)
n
i,j+ 12
− (cy)ni,j− 12
∆y
,
and
∇·(c∇v)ni,j=div(c∇v)ni,j
'
cn
i+ 12 ,j
(vx)
n
i+ 12 ,j
−cn
i− 12 ,j
(vx)
n
i− 12 ,j
∆x
+
cn
i,j+ 12
(vy)
n
i,j+ 12
−cn
i,j− 12
(vy)
n
i,j− 12
∆y
,
where 
cn
i,j+ 12
:=
cni,j+c
n
i,j+1
2 ,
cn
i,j− 12
:=
cni,j+c
n
i,j−1
2 ,
cn
i+ 12 ,j
:=
cni,j+c
n
i+1,j
2 ,
cn
i− 12 ,j
:=
cni,j+c
n
i−1,j
2 ,
are the midpoint approximations for c and
(cy)
n
i,j+ 12
:=
cni,j+1−cni,j
∆y ,
(cy)
n
i,j− 12
:=
cni,j−cni,j−1
∆y ,
(cx)
n
i+ 12 ,j
:=
cni+1,j−cni,j
∆x ,
(cx)
n
i− 12 ,j
:=
cni,j−cni−1,j
∆x ,
, and

(vy)
n
i,j+ 12
:=
vni,j+1−vni,j
∆y ,
(vy)
n
i,j− 12
:=
vni,j−vni,j−1
∆y ,
(vx)
n
i+ 12 ,j
:=
vni+1,j−vni,j
∆x ,
(vx)
n
i− 12 ,j
:=
vni,j−vni−1,j
∆x ,
represent the central differences for spatial derivatives of c and v. Note that
n = 0, 1, ..., k are index of time step, and (i, j) are spatial nodes where i = 1, ...q
are the indices for the x-direction and j = 1, ...q are the indices for the y-
direction. The diffusion terms in equations (8) -(10) are approximated in the
same way as it is in equation (6) and (7).
7.2 The computational microscopic scheme and its relation to the
macroscopic level
In this section, we describe our computational scheme for the micro scale
dynamics occurring on each microdomains Y ∈ P∗ , which are cubes of size
 located at the boundary ∂Ω(t0). We have each microdomain Y centred at
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a boundary point form the macroscopic mesh, with the neighbouring -cubes
staring from the centre of the current one (i.e. they are appropriately “half-
way shifted” copies of Y ∈ P∗ ), due to the purposely chosen macroscopic
mesh size h = 2 and the properties of the family P∗Y . Moreover, the centre
point of the microdomains are coincidentally the midpoint induced by Y on
[∂Ω(t0)]Y , i.e. x
∗
Y .
In order to compute the integrals in the source terms (i.e., f Y1 and f
Y
2 )
in the microscopic system (12) - (15), a midpoint rule is proposed and the
constitutive details are given below. Assuming that K denotes a generic ele-
ment domain in a finite element subdivision with either triangular or square
elements of a given region A ⊂ R2, this “midpoint rule” consists of approxi-
mating the integral of a function f over K as the product between the value
of f at the centre of mass of K, Kcentre, and the Lebesgue measure of K,
namely, ∫
K
f = f(Kcentre)λ(K). (42)
For an arbitrarily chosen Y ∈ P∗ , we consider a finite element approach
involving triangular elements on a uniform micro-mesh, which is maintained
with identical structure for all the micro-domains. Further, we consider a time-
constant approximation f˜ Y1 of f
Y
1 on the time interval [0, ∆t]. In this context,
using the computed final-time values of c(·, t0 +∆t) at the macro-mesh points
that are included on the current microdomain, x1, x2, ..., xPY ∈ Y ∩ Ω(t0),
we take:
f˜ Y1 (xs) =
1
λ(B(xs, 2) ∩Ω(t0))
∫
B(xs,2)∩Ω(t0)
c (xs, t0 +∆t) dx, (43)
where s = 1, ..., PY , and the integrals are computed via the midpoint rule.
For the rest of the points y on the micro-mesh, the value of f˜ Y1 is obtained
in terms of the set of finite element basis functions considered at the contact
points, i.e. , {φxs |s = 1, ..., PY }. Finally, we observe that for any micro mesh
point y ∈ Y we have two possibilities:
Case 1: If there exists three overlapping points xi1 , xi2 , xi3 ∈ {x1, x2, ..., xPY }
which belongs to the same connected component of Y ∩Ω(t0) and y belongs
to the convex closure of the set, i.e. , y ∈ Conv{xi1 , xi2 , xi3}, then we have:
f˜ Y1 (y) = f˜
Y
1 (xi1)φxi1 (y) + f˜
Y
1 (xi2)φxi2 (y) + f˜
Y
1 (xi3)φxi3 (y). (44)
Case 2: If y does not satisfies the conditions in Case 1, then we have
f˜ Y1 (y) = 0. (45)
For the source term f Y2 , we use the same approximation method as above,
except that there is only one case taken into consideration which is similar
in equation (44) according to the definition of f Y2 . Now we could obtain the
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source terms f˜ Y1 and f˜
Y
2 on each microdomain Y with zero initial condition
and Neumann boundary conditions and furthermore use the finite element
method to solve the reaction-diffusion equations (12) - (15) on Y over the
time interval [0, t0 + ∆t]. Then, we use bilinear elements on a square mesh,
the numerical scheme for the micro processes occurring on each Y is finally
obtained by involving a trapezoidal predictor-corrector method for the time
integration.
Then, for each microdomain we use the midpoint rule to compute the
transitional probability described in (37). For simplicity, now the numerical
implementation of the multiscale model for cancer invasion proposed above is
slightly simplified in the following way: provided that the transitional proba-
bility exceeds an associated threshold ωY ∈ (0, 1), the boundary mesh-point
x∗Y will move in direction ηY to the macro-mesh point from ∂Y \[Ω(t0)]Y
that is closest (in Euclidean distance) to x∗Y . If the threshold is not satisfied,
then x∗Y remains at the same spatial location. Therefore, the new bound-
ary ∂Ω(t0 + ∆t) is now obtained by the interpolation of the set of points
given in (38) , and the computational process is continued on the new domain
Ω(t0 +∆t) by using as a discretised version of (39) as a new initial condition
at the macroscopic stage, i.e.,
c(xi,j , t0 +∆t) =

cki,j , xi,j ∈ Ω(t0),
1
4 (c
k
i−1,j+c
k
i+1,j+c
k
i,j−1+c
k
i,j+1), xi,j ∈ B(Ω(t0), h)\Ω(t0),
0, xi,j /∈ B(Ω(t0), h),
(46)
and,
v(xi,j , t0 +∆t) = v
k
i,j , u(xi,j , t0 +∆t) = u
k
i,j ,
p(xi,j , t0 +∆t) = p
k
i,j , m(xi,j , t0 +∆t) = m
k
i,j . (47)
where {xi,j i, j = 1, ..., q} is the macroscopic mesh in Y, Ω(t0) is the topological
closure of Ω(t0), and B(Ω(t0), h) represents the topological closure of the h-
bundle of Ω(t0)., i.e., B(Ω(t0), h) := {x ∈ Y |∃zx ∈ Ω(t0) such that ||x −
zx||2 ≤ h}.
7.3 Overall algorithm steps
To sum up, the overall algorithm package of the macro-microscopic method
consists of the following steps:
A multiscale mathematical model of tumour invasive growth 37
Step 1: At the very begining time t0, first of all, we discretise the macro-
domain [a, b]× [c, d] by
a = x0, . . . , xi = a+ i∆x, . . . , xm = a+m∆x = b,
c = y0, . . . , yj = c+ j∆y, . . . , yn = c+ n∆y = d.
where ∆x = ∆y = h, h := 2 and let a = c = 0, c = d = 4. Also, we number
each point on the macro-domain, record their coordinates all sorts of data of
the domain that might be used later.
Step 2: Define initial conditions for cancer and ECM distribution on macro-
domain:
c(x, t0) =: c0(x), x ∈ Ω(t0)
v(x, t0) =: v0(x), x ∈ Ω(t0)
u(x, t0) =: u0(x), x ∈ Ω(t0)
p(x, t0) =: p0(x), x ∈ Ω(t0)
m(x, t0) =: m0(x), x ∈ Ω(t0)
where c(x, t0) is set as zero at the mesh points located outside the closure of
the macroscopic domain Ω(t0).
Step 3: Start the main time loop (from time stage 1 to certain time stage N),
and at the current time stage,
a) Run the macro-solver, which applies the finite difference scheme mentioned
above, to obtain the distribution of components in the system cn+1i,j v
n+1
i,j ,
un+1i,j , p
n+1
i,j , and m
n+1
i,j , where i, j = 1, ..., q.
b) Run the micro-solver, in which we loop over each points that was on the
boundary of tumour at previous time, and at an arbitrary boundary points,
i. Define the micro-domain Y centring at the current point on the bound-
ary, which consists of nine points on macrodomain. For simplicity, we
first construct the domain on [0, ]× [0, ] and on this domain compute
the source terms f Y1 and f
Y
2 , and by interpolation, we uniformly de-
compose the domain into sixty-four square elements consists of eighty-
one points in total, with the source term values and concentration values
for uPA, PAI-1 and plasmin on a finer mesh (see Figure 13).
ii. On the microdomain Y , apply the finite element method to solve the
microscopic dynamics system (12)-(15), to obtain the spatial distribu-
tion of plasmin at the final micro-time m(·, τf ) (involving a proposed
midpoint rule formula for the integral source terms f Y1 and f
Y
2 , and
for time integration a trapezoidal predictor-corrector), which will be
used in the regulation functions of cancer cells’ movement.
iii. Translated the coordinates on this microdomain back to where the mi-
cro spatial position was before.
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iv. Using the trasitional probability q∗ defined in (37), compute the inva-
sion strength as q∗(x∗Y ) := q
∗(Y ).
v. If and only if the microenvironment induced probability q∗(x∗Y ) is
greater than some tissue threshold value ωY ∈ (0, 1), we further com-
pute the direction ηY and magnitude ξY of the movement as described
by (35) and (36).
c) Once finishing both macro-solver and micro-solver at the current time
stage, we obtained new macroscopic distribution for each components in
the system cn+1i,j , v
n+1
i,j , u
n+1
i,j , p
n+1
i,j , and m
n+1
i,j ; also for each midpoint x
∗
Y
on the tumour boundary, we have the possibility q∗(x∗Y ), direction ηY
and magnitude ξY of their movement, therefore we could use all these in-
formation to determine the new position x˜∗Y and the points remain where
they were on the cancer interface ∂Ω(t0 +∆t). This is schematically shown
in Figure 13
Fig. 13: Plot shows the relocation of one point on the boundary moves to a
new spatial position in the microdomain Y .
where the red dots represent the discrete macro-mesh location for the where
micro-scale source induced by the macro-scale was calculated via the inte-
gral formula (43).
d) Finally, by using approximations shown in (46) and (47), replace the initial
values of cancer and ECM distribution in macroscopic dynamics with the
solution at the final time of the previous macro-step.
Step 4: Using the new initial conditions for macroscopic dynamics, continue
the invasion process by coupling the next-step macro-process given by the
system (6) and (10) on the expand domain Ω(t0 +∆t) with the corresponding
micro processes (12) - (15) occurring on its boundary, which means repeating
the Step 3 above with new initial conditions for macroscopic dynamics and
new boundary of cancer.
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Appendix: Table for the parameter set P
In Table 1 we present a description of the parameters included in P.
parameter value description
Dc 4.3× 10−3 diffusion of cancer cells
χu 3.05× 10−2 chemotaxis to uPA
χp 3.75× 10−2 chemotaxis to PAI-1
χv 2.85× 10−2 haptotaxis to ECM(vitronectin)
µ1 0.25 proliferation of cancer cells
δ 1.5 degradation of ECM
φ21 0.75 binding of uPA and PAI-1
φ22 0.55 binding of PAI-1 and VN
µ2 0.01 proliferation of ECM
Du 2.5× 10−3 diffusion of uPA
φ31 0.75 binding of uPA of PAI-1
φ33 0.3 binding of uPA and uPAR
α31 0.215 production of uPA
Dp 3.5× 10−3 diffusion of PAI-1
φ41 0.75 binding of uPA and PAI-1
φ42 0.55 binding of PAI-1 and VN
α41 0.5 production of PAI-1
Dm 4.91× 10−3 diffusion of plasmin
φ52 0.11 increase rate due to binding of PAI-1 and VN
φ53 0.75 increase rate due to binding of uPA and uPAR
φ54 0.5 degradation of plasmin
Table 1: The parameters in P.
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